510(k) K192175
K192175 is an FDA 510(k) premarket notification submitted by ACON Laboratories, Inc. for the device "On Call Express II Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on Oct 17, 2019. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345. ACON Laboratories, Inc. has 92 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 17, 2019
- Date Received
- Aug 12, 2019
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Blood Glucose, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for ACON Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.